Chat with us, powered by LiveChat
3rd New Product Planning Summit -

3rd New Product Planning Summit
December 12 - 13, 2018
Boston, MA

Understand how to navigate the changing regulatory landscape and effectively manage resources and timelines

Agenda – 3rd New Product Planning Summit



Day One

 Wednesday, December 12

8:45AM – 9:00AM

Chairperson’s Opening Remarks


Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

9:00AM – 9:45AM

Begin With the End In Mind: Why Getting It Right From the Start Is the Most Important Step in the Ongoing Process of New Product Planning


Dr. Raymond Donninger, Vice President, Head of Insights and Analytics, PRESCIENT HEALTHCARE GROUP
Dr. Paul Harney, President, North America, PRESCIENT HEALTHCARE GROUP

9:45AM – 10:30AM

Interactive Group Discussion


Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

10:30AM – 11:00AM

Networking Break


11:00AM – 11:45AM

Develop a Commercially and Clinically Viable Differentiation Strategy — Then Validating It 


Brad Payne, MBA, Partner, ARTISAN HEALTHCARE CONSULTING

11:45AM – 12:30PM

Target Product Profile (TPP) – Development and Evolution from Pre-Clinical to Product Approval


Vincent Fisher, Director, Commercial Planning - HIV, Gilead Sciences

12:30PM – 1:30PM

Luncheon


1:30PM – 2:15PM

Appropriate Value-Based Decisions Into Clinical Development


John Sears, Ph.D., MBA, Health Care Quality and Commercial Strategy Director, JOHNSON & JOHNSON

2:15PM – 3:00PM

Panel: When Do You Incorporate Market Access Considerations Into Product Commercialization?


John Sears, Ph.D., MBA, Health Care Quality and Commercial Strategy Director, JOHNSON & JOHNSON
Jennifer Sherak, B.A., MBA, Global Head, Oncology New Product Planning, Takeda Pharmaceuticals
Joel Sangerman, Chief Commercial Officer, Click Therapeutics

3:00PM – 3:30PM

Networking Break


3:30PM – 4:15PM

When to Transition an Asset From New Products to In-Line Marketing?


Karen McCulloch, Global Marketing Director, Respiratory Early Pipeline, GlaxoSmithKline

4:15PM – 5:00PM

The Intersection of Drugs and Digital: A Look Ahead and the Implications for New Product Planners


Jake Schutz, Vice President, Southwest Lead, Promidian Consulting


Day Two

 Thursday, December 13

8:00AM – 9:00AM

Continental Breakfast


9:00AM – 9:15AM

Chairperson's Recap of Day One


Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

9:15AM – 10:00AM

How to Work Effectively With Research Teams in New Product Planning


Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

10:00AM – 10:45AM

Effectively Partner With Clinical, Regulatory, and Translational Colleagues to Prepare the Marketplace Ahead of a Launch


Charles Pak, Vice President, New Product Planning, SYROS PHARMACEUTICALS

10:45AM – 11:15AM

Networking Break


11:15AM – 12:15PM

Lessons From Emerging Biopharma Companies Commercializing Their First Asset


Bart J. Lombardi, Founder and Managing Director, CLARION HEALTHCARE | A LIFE SCIENCES CONSULTANCY
John Garcia, Global Commercial Excellence Lead, ALNYLAM PHARMACEUTICALS
Sarah Kurz, Chief Commercial Officer, PARTNER THERAPEUTICS
Scott T. Megaffin, Chief Executive Officer, TRAGARA PHARMACEUTICALS INC.

12:15PM – 1:15PM

Luncheon


1:15PM – 2:00PM

Develop a Go-to-Market Strategy Ahead of Product Launch


Aakanksha Khandelwal, Ph.D., MBA, Head of Innovation & Scientific Leadership, EMD SERONO

2:00PM – 2:45PM

CMC Perspectives for Global Launch for Oral and Combination Drug Products


Abizer Harianawala, Ph.D., Senior Director, Product Development and Technical Operations, TARIS BIOMEDICAL

2:45PM – 3:00PM

Chairperson's Closing Remarks


Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA


live chat software